AzTrials
AzTrials

StrokeNCT02399540

Late LTP-like Plasticity Effects of tDCS in Chronic Stroke Patients

A study testing Conventional Paired tDCS, Conventional Unpaired tDCS and Late LTP-like Plasticity tDCS in people with Stroke and Hemiparesis, run by Erasmus Medical Center at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Rationale: About 80% of stroke patients suffer motor impairments, but current therapies have limited effects on motor recovery. Therefore, investigating new potential therapeutic approaches is crucial. Read more about this study

Who is it for?
Ages 18 to 79 years
Conditions the study is for
Stroke, Hemiparesis
What is being tested?
Conventional Paired tDCS, Conventional Unpaired tDCS and Late LTP-like Plasticity tDCS
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
84 participants
Where
1 siteNetherlands
Study dates
Mar 2015to May 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 79 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Chronic (> 6 months) stroke patient
  • Aged 18-79 years
  • Motor deficit in the upper limb due to the stroke

Who cannot join

  • Absence of recordable MEPs from the ADM after TMS
  • Absence of voluntary movement (Fugl-Meyer < III)
  • Head injury or the presence of intracranial metal or intracranial lesions
  • History of cranial irradiation
  • History of epilepsy
  • Presence of a pacemaker
Show all 10Show fewer
  • Taking anticonvulsant or neuroleptic medication
  • Substance abuse
  • Inability to understand instructions
  • History of psychiatric disorders

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Rijndam

    Rotterdam, South Holland, 3015LJ

Other trials in Netherlands

About this study

Rationale: About 80% of stroke patients suffer motor impairments, but current therapies have limited effects on motor recovery. Therefore, investigating new potential therapeutic approaches is crucial. Transcranial Direct Current Stimulation (tDCS) is a form of non-invasive electrical stimulation where a weak current is applied through electrodes over the scalp. This stimulation is known to (1) induce changes in neuronal excitability -which can last up to one day with late LTP-like plasticity protocols- in a polarity and site-specific manner, and (2) facilitate motor learning and stroke recovery. However, it is unknown how the motor cortex excitability changes that follow tDCS relate to the increase in motor learning and recovery potential. The currently upheld hypothesis is that motor learning needs to be synchronized in time with electrical stimulation (paired stimulation), but recent results from our lab suggest that tDCS also increases skill learning after stimulation has ended (unpaired stimulation). If this is true, tDCS has a much larger therapeutic window and is a more valuable clinical tool than currently believed. Therefore, the investigators want to investigate how late LTP-like plasticity tDCS affects the increase in skill learning normally seen with tDCS when applied 24 hours before training. The outcome of this study can provide important guidelines on effective motor therapy during stroke rehabilitation.

Objective: Identify the effect of late LTP-like plasticity tDCS in chronic stroke patients on skill learning 24 hours later.

Study design: Double-blinded, randomized between-subjects trials. Study population: Chronic stroke patients. Main study parameters/endpoints: The main objective of the study is to determine the effect of late LTP-like plasticity tDCS on skill learning 24 hours later. As a motor learning paradigm, the investigators will use a circuit tracking task which chronic stroke patients perform better if tDCS is applied concurrently. During this task, patients have to trace a cursor over a circuit as fast and accurately as possible by moving a computer mouse. Skill will be quantified by calculating a combined speed/ accuracy score and skill improvement compared to baseline (LI; the learning index) will be compared between the sham, conventional unpaired tDCS, conventional paired tDCS groups and the late LTP-like plasticity tDCS groups.

Conditions
Stroke, Hemiparesis
Being tested
Sham, Conventional Paired tDCS, Conventional Unpaired tDCS, Late LTP-like Plasticity tDCS
Medical subject headings
Stroke, Paresis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ShamDevice

    Bihemispheric 1mA Sham protocol: sham - pause - sham

  • Conventional Paired tDCSDevice

    Bihemispheric 1mA Sham protocol: sham - pause - sham Conventional Paired tDCS protocol: 20 minutes tDCS - pause - sham

  • Conventional Unpaired tDCSDevice

    Bihemispheric 1mA Sham protocol: sham - pause - sham Conventional Unpaired tDCS protocol: 20 minutes tDCS - pause - sham

  • Late LTP-like Plasticity tDCSDevice

    Bihemispheric 1mA Sham protocol: sham - pause - sham Late LTP-like Plasticity tDCS protocol: 10 minutes tDCS - 25 minutes pause - 10 minutes tDCS

Study groups in NCT02399540
Study groupRoleWhat they receive
ShamSham comparatorDay 1: sham stimulation Day 2: sham stimulation
Receives: Device: Sham
Conventional Paired tDCSActive comparatorDay 1: sham stimulation Day 2: conventional tDCS
Receives: Device: Conventional Paired tDCS
Conventional Unpaired tDCSActive comparatorDay 1: conventional tDCS Day 2: sham stimulation
Receives: Device: Conventional Unpaired tDCS
Late LTP-like Plasticity tDCSExperimentalDay 1: late LTP-like Plasticity tDCS Day 2: sham stimulation
Receives: Device: Late LTP-like Plasticity tDCS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Motor Skill Retention

    Motor skill retention will be assessed on the circuit game

    Measured: Day 9

Secondary outcomes (2)
  1. Maximum Grip Force

    Maximum Grip Force will be assessed using a Jamar Dynamometer

    Measured: Day 1 and Day 9

  2. Purdue Pegboard Test

    Measured: Day 1 and Day 9

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Mar 2015 (estimated)
  2. Study startMar 2015
  3. Primary completionMay 2016
  4. Study completionMay 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
84 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02399540
Sponsor's protocol ID
MEC-2014-203
Status last verified
Aug 2016
First submitted
15 Mar 2015
Last updated
2 Aug 2016
Results posted
No
Data monitoring committee
No

Publications

  • Lefebvre S, Laloux P, Peeters A, Desfontaines P, Jamart J, Vandermeeren Y. Dual-tDCS Enhances Online Motor Skill Learning and Long-Term Retention in Chronic Stroke Patients. Front Hum Neurosci. 2013 Jan 9;6:343. doi: 10.3389/fnhum.2012.00343. eCollection 2012.

    PubMed 23316151
  • Elsner B, Kugler J, Pohl M, Mehrholz J. Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke. Cochrane Database Syst Rev. 2020 Nov 11;11(11):CD009645. doi: 10.1002/14651858.CD009645.pub4.

    PubMed 33175411
  • van der Vliet R, Ribbers GM, Vandermeeren Y, Frens MA, Selles RW. BDNF Val66Met but not transcranial direct current stimulation affects motor learning after stroke. Brain Stimul. 2017 Sep-Oct;10(5):882-892. doi: 10.1016/j.brs.2017.07.004. Epub 2017 Jul 13.

    PubMed 28751226

Questions about this trial

What is this clinical trial studying?

A study testing Conventional Paired tDCS, Conventional Unpaired tDCS and Late LTP-like Plasticity tDCS in people with Stroke and Hemiparesis, run by Erasmus Medical Center at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Aug 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Motor Skill Retention (time frame: Day 9). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02399540, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in